Published on 7/30/2009 in the Prospect News PIPE Daily.
New Issue: NeoGenomics completes $4.77 million private placement of common stock
By Devika Patel
Knoxville, Tenn., July 30 - NeoGenomics, Inc. settled a $4.77 million private placement of shares on July 24, according to an 8-K filed Thursday with the Securities and Exchange Commission and a company news release.
The company sold 3.5 million common shares to Abbott Laboratories.
Based in Fort Myers, Fla., NeoGenomics is a cancer genetics diagnostics testing company.
| Issuer: | NeoGenomics, Inc.
|
| Issue: | Common stock
|
| Amount: | $4,767,000
|
| Shares: | 3.5 million
|
| Warrants: | No
|
| Investor: | Abbott Laboratories
|
| Settlement date: | July 24
|
| Stock symbol: | OTCBB: NGNM
|
| Stock price: | $1.85 at close July 24
|
| Market capitalization: | $62.8 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
